GlassScriptPhysician profile
Alyssa Jenkins
NPI 1922455740
$1,443.59
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7.29 · 2020: $197 · 2021: $162 · 2022: $204 · 2023: $785 · 2024: $88.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $519 · Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $518.77 |
| Food and Beverage | $354.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hu-Friedy Mfg. Co., LLC | $518.77 | 2023 | |
| Align Technology, INC. | $235.63 | 2020-2021 | |
| Zimvie INC. | $196.47 | 2022-2023 | |
| Centrix INC | $101.06 | 2020 | |
| Nobel Biocare USA | $84.61 | 2023 | Nobelactive |
| Kerr Corporation | $84.61 | 2023 | Harmonize |
| Ivoclar Vivadent, INC. | $74.28 | 2024 | |
| Dentsply Sirona INC | $62.46 | 2022-2023 | Implant Dentistry |
| 3m Company | $41.80 | 2023 | Scotchbond Universal Plus, Filtek, 3m Filtek |
| Abbvie INC. | $16.91 | 2021 | |
| Philips North America LLC | $14.24 | 2024 | (3110) Ohc Und |
| Biolase, INC. | $7.29 | 2019 | |
| Coltene Whaledent INC. | $5.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.